Late relapses of hepatitis C virus-cured mixed cryoglobulinaemia associated with infection or cancer

Rheumatology (Oxford). 2018 Oct 1;57(10):1870-1871. doi: 10.1093/rheumatology/key157.

Authors

Marcella Visentini¹, Luca Quartuccio², Martina Del Padre^{1

3}, Stefania Colantuono^{1

3}, Ylenia A Minafò^{1

3}, Massimo Fiorilli¹, Salvatore De Vita², Milvia Casato¹

Affiliations

¹ Department of Clinical Medicine, Sapienza University of Rome, Rome; Laboratory affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Italy.
² Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital 'Santa Maria della Misericordia', Udine, Italy.
³ Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.

PMID: 29868896
DOI: 10.1093/rheumatology/key157

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Aged, 80 and over
Antiviral Agents / therapeutic use
Cryoglobulinemia / complications
Cryoglobulinemia / drug therapy
Cryoglobulinemia / virology*
Cryoglobulins / analysis
Female
Hepacivirus*
Hepatitis C, Chronic / complications*
Hepatitis C, Chronic / drug therapy
Humans
Middle Aged
Neoplasms / etiology*
Neoplasms / virology
Recurrence
Sustained Virologic Response
Vasculitis / etiology*
Vasculitis / virology

Substances

Antiviral Agents
Cryoglobulins